News

Hologic Received FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio On February 04, 2026, Hologic, Inc. announced…

The American Society of Hematology (ASH) has released clinical practice guidelines on the diagnosis of light chain (AL) amyloidosis, which were published in…

For Marvin Hudson, a dedicated Miami-Dade police officer, retirement in 2018 marked the end of a distinguished career and the beginning of a new chapter with his…

AbstractBackground: Transthyretin (TTR) amyloid deposition in the tenosynovium in carpal tunnel syndrome (CTS) is a potential early manifestation of systemic…

DUBLIN--(BUSINESS WIRE)-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics…

− Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared…

Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCOInternational Myeloma Foundation Chief Medical OfficerTGen, City of Hope Cancer Center—Phoenix, AZ, USADr. Mikhael is a…

The Purple Ball gala dinner returns to Glasgow this Valentine’s Day for its 12th year, continuing to raise vital funds…

Join the National Organization for Rare Disorders® for a webinar focused on state advocacy on Thursday, February 12 at 1pm ET! We’ll be rolling out the 11th annual…

As an advocate for the New Zealand Amyloidosis Patients Association since 2019, I am acutely aware that when there is no center of excellence or…